本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 交易简要内容：华润双鹤药业股份有限公司(以下简称"华润双鹤"或"公司")拟投资设立华润双鹤生物 医药产业基金(呼和浩特)投资合伙企业(有限合伙)(暂定名，以工商核准名为准，以下简称"华润双鹤产 业基金"或"该基金")，基金目标募集规模为5亿元人民币，公司及全资子公司双鹤(北京)生物技术有限公 司(以下简称"双鹤生物")拟以自有资金出资不超过8,700万元人民币，占基金总出资额的比例不超过 17.40%。 ● 本次交易构成关联交易，不构成重大资产重组。 ● 本次交易金额超过3,000万元，未超过公司2024年度经审计净资产的5%，已经董事会审议批准，无需 提交股东会审议。 ● 过去12个月内，除日常关联交易及本次交易外，公司拟以自有资金4,000万元人民币与华润医药投资 有限公司等11家合伙人共同投资设立华润医药(成都)创新投资基金合伙企业(有限合伙)(以下简称"华润 医药产业投资基金二期")，基金目标募集规模为10亿元人民币，公司出资比例为4.00%。除前述交 ...

Group 1 - China Resources Pharmaceutical (03320) announced a collaboration to establish a fund with an expected scale of RMB 500 million [1] - The fund is anticipated to focus on high-growth investments in synthetic biology, innovative drugs, and biotechnology sectors [1] - The company plans to commit a total investment of up to RMB 123 million, representing approximately 24.6% of the total committed capital for the fund [1] Group 2 - The fund is expected not to be accounted as a subsidiary of the company after its establishment [1] - Shenzhen China Resources Capital is expected to be appointed as the fund manager [1]

Core Viewpoint - China Resources Pharmaceutical (03320) is collaborating with partners to establish a fund with an expected scale of RMB 500 million, focusing on high-growth investments in synthetic biology, innovative drugs, and biotechnology sectors [1] Company Summary - The company plans to commit a total investment of up to RMB 123 million, which represents approximately 24.6% of the total committed capital for the fund [1] - The fund is expected not to be accounted as a subsidiary of the company after its establishment [1] - Shenzhen China Resources Capital is anticipated to be appointed as the fund manager [1]

Group 1 - China Resources Pharmaceutical (03320) announced a collaboration with its subsidiaries and Hanwei Huayou Shantou to establish a fund with an expected scale of RMB 500 million [1] - The fund is anticipated to focus on high-growth investments in synthetic biology, innovative drugs, and biotechnology sectors [1] - The company plans to commit a total investment of up to RMB 123 million, representing approximately 24.6% of the total fund commitment [1] - The fund is expected not to be accounted as a subsidiary of the company upon establishment [1] - Shenzhen China Resources Capital is expected to be appointed as the fund manager [1]

Group 1 - The core announcement involves China Resources Pharmaceutical (03320.HK) planning to establish a fund with an expected scale of RMB 500 million, focusing on investments in high-growth companies in synthetic biology, innovative drugs, and biotechnology [1] - The company intends to commit a total investment of up to RMB 123 million, which represents approximately 24.6% of the total committed capital for the fund [1] - Shenzhen China Resources Capital is expected to be appointed as the fund manager after its establishment [1]

【环球时报报道 记者 李迅典】"美国加征关税重塑世界贸易格局，韩越领导人承诺深化双边关系。"路 透社11日报道称，应韩国总统李在明邀请，越共中央总书记苏林于8月10日至13日对韩国进行国事访 问。韩国《中央日报》称，这是越共中央总书记11年来首次访韩，苏林也成为李在明上任后接待的首位 外国领导人。 韩联社称，李在明还邀请苏林出席将于10月在庆州举行的亚太经合组织（APEC）第三十二次领导人非 正式会议，苏林对此予以积极回应。 据报道，李在明与苏林11日在首尔龙山总统府举行会谈，宣布计划将双边贸易额从2024年的约868亿美 元提升至2030年的1500亿美元，双方签署多项关键领域合作协议。韩总统办公室称，两国还签署了10项 谅解备忘录，承诺在核能、可再生能源、货币金融政策、科技等领域开展合作。李在明称，两国将加速 推进核电、高速铁路及智慧城市等大型基础设施项目合作，并在人工智能、生物技术、芯片研发等新兴 领域加强协作。他表示，希望 "依托韩国企业卓越的技术实力和丰富经验，涌现出成功的合作案例"。 苏林则呼吁韩方继续为越南培养高端技术人才，并支持韩国企业扩大在越投资规模。 ...

（文章来源：央视新闻） 据中国科学院遗传与发育生物学研究所消息，该研究所许操研究员带领的智能育种攻关团队将BT（生 物技术）与AI（人工智能）深度融合，首次提出作物-机器人协同设计理念，通过基因编辑重新设计作 物花型，快速精准创制"机器人友好"的结构型雄性不育系，运用深度学习和人工智能成功研制出世界首 台可自动巡航杂交授粉的智能育种机器人"吉儿"（GEAIR），打破杂交育种和制种瓶颈，可大幅降低育 种成本、缩短育种周期、提高育种效率。这一成果北京时间8月11日在国际学术期刊《细胞》发表。 ...

Group 1 - The Indian MSCI index has underperformed the Chinese stock market by approximately 10 percentage points this quarter, potentially marking the largest annual performance gap since 2017 [1][4] - Goldman Sachs predicts that the Indian stock market will continue to lag behind other emerging markets, maintaining a "neutral" rating on Indian stocks while reiterating an "overweight" stance on Chinese stocks and raising the 12-month target for the MSCI China index [4][6] - The market dynamics have shifted due to the recent imposition of a 25% additional tariff on Indian goods by Trump, which has led to a significant capital outflow from India, with around $3 billion leaving the market last month, the largest monthly outflow since February [4][6] Group 2 - The trade dispute has reshaped the investment landscape between China and India, with the recent tariff actions being particularly targeted and sudden [5] - The deteriorating US-India relations and new tariffs may undermine India's manufacturing ambitions, causing investor concerns regarding India's high valuations and slowing profit growth [7][8] - In contrast, China offers more attractive investment opportunities in rapidly growing sectors such as artificial intelligence, clean energy, and biotechnology, which may support the "buy China" investment logic in the short term [9]

Core Viewpoint - The imposition of a 25% additional tariff on Indian goods by the Trump administration is reshaping the investment landscape in Asia, leading to a shift from "buying India" to "buying China" among investors [1][2]. Group 1: Market Performance - The MSCI India index has underperformed the Chinese stock market by approximately 10 percentage points this quarter, potentially marking the largest annual performance gap since 2017 [2]. - Foreign investors withdrew about $3 billion from the Indian stock market last month, the highest monthly outflow since February of this year [3][4]. Group 2: Investment Strategy Adjustments - Goldman Sachs maintains a "market weight" view on the Indian stock market while reiterating an "overweight" stance on the Chinese market, raising the 12-month target for the MSCI China index [2][3]. - The market capitalization gap between Chinese and Indian stock markets has widened to $6.3 trillion, the largest since March [2]. Group 3: Trade Relations and Market Sentiment - The sudden and targeted nature of the tariffs has escalated trade tensions, affecting market sentiment and investor confidence in India [3]. - Analysts express concerns over India's high valuations and slowing profit growth, which may lead to further foreign fund sell-offs [3][4]. Group 4: Comparative Valuation - The MSCI India index is currently trading at over 21 times its one-year forward earnings, while the Chinese index is at 11.9 times, making China more attractive for value investors [4]. - The ongoing trade uncertainties may position Indian stocks as secondary in regional allocations, with potential for increased foreign fund selling [4]. Group 5: Long-term Outlook for India - Despite short-term challenges, India's long-term economic trajectory remains appealing to some investors, with Morgan Stanley predicting that India's stock market could reach new highs due to strong population growth and improving fundamentals [5].

Group 1 - The Ministry of Education and Training in Vietnam launched a network of six outstanding technical training centers focusing on fields such as artificial intelligence, semiconductors, biotechnology, renewable energy, and educational technology [1] - The centers are led by various universities, including the Southern AI and Semiconductor Network by the University of Science under the National University of Ho Chi Minh City, and the Central AI and Semiconductor Network by Da Nang University [1] - The establishment of this network signifies a shift in Vietnam's higher education from isolated development to collaborative networking, enhancing the quality of training and research through strategic alliances between universities and enterprises [2] Group 2 - The Deputy Minister of Education and Training emphasized the critical role of universities in promoting technological innovation and the importance of aligning research activities with enterprise needs to ensure practical application of research outcomes [2] - The network aims to create an open innovation ecosystem through collaboration among schools, businesses, and the government, allowing for the realization of creative ideas [2] - Members of the outstanding technical training center network include domestic and international universities, research institutes, and enterprises, focusing on talent development, technology research, technology transfer, and resource sharing [2]